Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 USD | +1.68% | -3.69% | +132.22% |
May. 14 | Earnings Flash (PYXS) PYXIS ONCOLOGY Posts Q1 Revenue $16.1M | MT |
May. 14 | Pyxis Oncology, Inc. Appoints Stephen Worsley as its Senior Vice President | CI |
Business Summary
Number of employees: 50
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Pamela Connealy
DFI | Director of Finance/CFO | 63 | 21-06-30 |
Chief Tech/Sci/R&D Officer | - | - | |
Jan Pinkas
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Ken Kobayashi
CTO | Chief Tech/Sci/R&D Officer | - | Nov. 26 |
Jitendra Wadhane
AUD | Comptroller/Controller/Auditor | 44 | 21-07-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Flavin
FOU | Founder | 55 | 18-06-10 |
Freda Lewis-Hall
BRD | Director/Board Member | 69 | 21-08-31 |
Darren Cline
BRD | Director/Board Member | 59 | 21-08-31 |
Jakob Dupont
BRD | Director/Board Member | 58 | 23-08-22 |
Rachel Humphrey
BRD | Director/Board Member | 62 | 22-08-10 |
Thomas Civik
BRD | Director/Board Member | 55 | 21-08-31 |
Lara Sullivan
CEO | Chief Executive Officer | 51 | 19-12-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 58,888,473 | 47,191,720 ( 80.14 %) | 0 | 80.14 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+132.22% | 246M | |
+8.63% | 114B | |
+10.88% | 104B | |
-12.56% | 22.41B | |
-0.52% | 22.28B | |
-5.80% | 19.07B | |
-37.36% | 18B | |
-5.29% | 17.89B | |
+7.26% | 14.28B | |
+36.51% | 12.55B |
- Stock Market
- Equities
- PYXS Stock
- Company Pyxis Oncology, Inc.